Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C>T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms

References

• Olcaydu D, Harutyunyan A, Jäger R, Berg T, Gisslinger B, Pabinger I, et al. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet 2009;41:450–4. doi: 10.1038/ng.341
   PubMed Web of Science ®Google Scholar
• Jones AV, Chase A, Silver RT, Oscier D, Zoi K, Wang YL, et al. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet 2009;41:446–9. doi: 10.1038/ng.334
   PubMed Web of Science ®Google Scholar
• Oddsson A, Kristinsson SY, Helgason H, Gudbjartsson DF, Masson G, Sigurdsson A, et al. The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms. Leukemia 2014;28:1371–4. doi: 10.1038/leu.2014.48
   PubMed Web of Science ®Google Scholar
• Tapper W, Jones AV, Kralovics R, Harutyunyan AS, Zoi K, Leung W, et al. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. Nat Commun 2015;6:6691. doi: 10.1038/ncomms7691
   PubMed Web of Science ®Google Scholar
• Gavalas NG, Akhtar S, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem Biophys Res Commun 2006;345:1586–91. doi: 10.1016/j.bbrc.2006.05.063
   PubMed Web of Science ®Google Scholar
• Kang D, Lee KM, Park SK, Berndt SI, Peters U, Reding D, et al. Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study. Cancer Epidemiol Biomarkers Prev 2007;16:1581–6. doi: 10.1158/1055-9965.EPI-07-0160
   PubMed Web of Science ®Google Scholar
• Wang S, Wang F, Shi X, Dai J, Peng Y, Guo X, et al. Association between manganese superoxide dismutase (MnSOD) Val-9Ala polymorphism and cancer risk – a meta-analysis. Eur J Cancer 2009;45:2874–81. doi: 10.1016/j.ejca.2009.04.024
   PubMed Web of Science ®Google Scholar
• Men T, Zhang X, Yang J, Shen B, Li X, Chen D, et al. The rs1050450 C>T polymorphism of GPX1 is associated with the risk of bladder but not prostate cancer: evidence from a meta-analysis. Tumour Biol 2014;35:269–75. doi: 10.1007/s13277-013-1035-1
   PubMed Web of Science ®Google Scholar
• Buchard A, Sanchez JJ, Dalhoff K, Morling N. Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants: simultaneously detecting GSTM1 and GSTT1 gene copy number and the allelic status of the GSTP1 Ile105Val genetic variant. J Mol Diagn 2007;9:612–7. doi: 10.2353/jmoldx.2007.070030
   PubMed Web of Science ®Google Scholar
• Fang J, Wang S, Zhang S, Su S, Song Z, Deng Y, et al. Association of the glutathione s-transferase m1, t1 polymorphisms with cancer: evidence from a meta-analysis. PLoS ONE 2013;8:e78707. doi: 10.1371/journal.pone.0078707
   PubMedGoogle Scholar
• Anderson LA, Duncombe AS, Hughes M, Mills ME, Wilson JC, McMullin MF. Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms. Am J Hematol 2012;87:175–82. doi: 10.1002/ajh.22212
   PubMed Web of Science ®Google Scholar
• Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005;106:2162–8. doi: 10.1182/blood-2005-03-1320
   PubMed Web of Science ®Google Scholar
• Furtado LV, Weigelin HC, Elenitoba-Johnson KS, Betz BL. Detection of MPL mutations by a novel allele-specific PCR-based strategy. J Mol Diagn 2013;15:810–8. doi: 10.1016/j.jmoldx.2013.07.006
   PubMed Web of Science ®Google Scholar
• Trifa AP, Cucuianu A, Popp RA. Familial essential thrombocythemia associated with MPL W515L mutation in father and JAK2 V617F mutation in daughter. Case Rep Hematol 2014;2014:841787.
   PubMedGoogle Scholar
• Suzen HS, Gucyener E, Sakalli O, Uckun Z, Kose G, Ustel D, et al. CAT C-262T and GPX1 Pro198Leu polymorphisms in a Turkish population. Mol Biol Rep 2010;37:87–92. doi: 10.1007/s11033-009-9540-4
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Sun D, Li Z, Wang L, Liu P. Genetic polymorphisms of superoxide dismutases, catalase, and glutathione peroxidase in age-related cataract. Mol Vis 2011;17:2325–32.
   PubMed Web of Science ®Google Scholar
• Montano MA, Barrio Lera JP, Gottlieb MG, Schwanke CH, da Rocha MI, Manica-Cattani MF, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and elderly obesity. Mol Cell Biochem 2009;328:33–40. doi: 10.1007/s11010-009-0071-z
   PubMed Web of Science ®Google Scholar
• Hohaus S, Di Ruscio A, Di Febo A, Massini G, D'Alo F, Guidi F, et al. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res 2005;11:2175–9. doi: 10.1158/1078-0432.CCR-04-1250
   PubMed Web of Science ®Google Scholar
• Wilson MH, Grant PJ, Hardie LJ, Wild CP. Glutathione S-transferase M1 null genotype is associated with a decreased risk of myocardial infarction. FASEB J 2000;14:791–6.
   PubMed Web of Science ®Google Scholar
• Lightfoot TJ, Skibola CF, Smith AG, Forrest MS, Adamson PJ, Morgan GJ, et al. Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica 2006;91:1222–7.
   PubMed Web of Science ®Google Scholar
• Bănescu C, Trifa AP, Voidăzan S, Moldovan VG, Macarie I, Benedek Lazar E, et al. CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case–control study. Oxid Med Cell Longev 2014;2014:875861.
   PubMed Web of Science ®Google Scholar
• Wang SS, Davis S, Cerhan JR, Hartge P, Severson RK, Cozen W, et al. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis 2006;27:1828–34. doi: 10.1093/carcin/bgl013
   PubMed Web of Science ®Google Scholar
• Naffa RG, Awidi AS, Yousef AM, Ismail SI. CYP1AI, glutathione S-transferase gene polymorphisms and risk of polycythemia vera. Cancer Epidemiol 2012;36:68–72. doi: 10.1016/j.canep.2011.05.001
   PubMed Web of Science ®Google Scholar